{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:31:16Z","timestamp":1712536276408},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,6]]},"DOI":"10.7759\/cureus.57741","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T05:14:31Z","timestamp":1712466871000},"source":"Crossref","is-referenced-by-count":0,"title":["Embolic Strokes in Paroxysmal Atrial Fibrillation: Anticoagulation Failure or Something Else?"],"prefix":"10.7759","author":[{"given":"Muhammad Umer Riaz","family":"Gondal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Asad","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayab","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaib","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000015029.91577.36","article-title":"Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study","volume":"33","author":"Singhal AB","year":"2002","unstructured":"Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002, 33:1267-73. 10.1161\/01.str.0000015029.91577.36","journal-title":"Stroke"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib G","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al.. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015, 36:3075-128. 10.1093\/eurheartj\/ehv319","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study","volume":"36","author":"Marini C","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005, 36:1115-9. 10.1161\/01.STR.0000166053.83476.4a","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00500-x","article-title":"The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades","volume":"42","author":"Tsang TS","year":"2003","unstructured":"Tsang TS, Petty GW, Barnes ME, et al.. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol. 2003, 42:93-100. 10.1016\/s0735-1097(03)00500-x","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.7.733","article-title":"A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism","volume":"165","author":"Wells PS","year":"2005","unstructured":"Wells PS, Anderson DR, Rodger MA, et al.. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2005, 165:733-8. 10.1001\/archinte.165.7.733","journal-title":"Arch Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00309-3","article-title":"Hemorrhagic complications of intravenous heparin use","volume":"80","author":"Juergens CP","year":"1997","unstructured":"Juergens CP, Semsarian C, Keech AC, Beller EM, Harris PJ. Hemorrhagic complications of intravenous heparin use. Am J Cardiol. 1997, 80:150-4. 10.1016\/s0002-9149(97)00309-3","journal-title":"Am J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour LM","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, et al.. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015, 132:1435-86. 10.1161\/CIR.0000000000000296","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S113385","article-title":"Insidious onset of intermittent claudication as the primary manifestation of infective endocarditis","volume":"10","author":"Vasquez-Rios G","year":"2017","unstructured":"Vasquez-Rios G, Gamero MT, De la Cruz J, Hernandez GA, Hernandez E, Due\u00f1as R. Insidious onset of intermittent claudication as the primary manifestation of infective endocarditis. Int J Gen Med. 2017, 10:11-4. 10.2147\/IJGM.S113385","journal-title":"Int J Gen Med"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-111108","article-title":"Treatment failure in patients receiving direct oral anticoagulants: clinical management and outcomes from a single-center review of 59 consecutive patients","volume":"132","author":"McIlroy G","year":"2018","unstructured":"McIlroy G, Smith N, Lokare A, Beale K, Kartsios C. Treatment failure in patients receiving direct oral anticoagulants: clinical management and outcomes from a single-center review of 59 consecutive patients. Blood. 2018, 132:5058-10.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01100.x","article-title":"A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial","volume":"3","author":"Eriksson BI","year":"2005","unstructured":"Eriksson BI, Dahl OE, B\u00fcller HR, et al.. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost. 2005, 3:103-11. 10.1111\/j.1538-7836.2004.01100.x","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01602.x","article-title":"BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study","volume":"3","author":"Turpie AG","year":"2005","unstructured":"Turpie AG, Fisher WD, Bauer KA, et al.. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost. 2005, 3:2479-86. 10.1111\/j.1538-7836.2005.01602.x","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 383:955-62. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"van Es RF","year":"2002","unstructured":"van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 2002, 360:109-13. 10.1016\/S0140-6736(02)09409-6","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240846-embolic-strokes-in-paroxysmal-atrial-fibrillation-anticoagulation-failure-or-something-else","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T05:14:35Z","timestamp":1712466875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240846-embolic-strokes-in-paroxysmal-atrial-fibrillation-anticoagulation-failure-or-something-else"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.57741","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,6]]}}}